These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 21143421

  • 1. Comparison of the first intake of vardenafil and tadalafil in patients with diabetic neuropathy and diabetic erectile dysfunction.
    Kamenov ZA.
    J Sex Med; 2011 Mar; 8(3):851-64. PubMed ID: 21143421
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.
    Schneider T, Gleissner J, Merfort F, Hermanns M, Beneke M, Ulbrich E.
    J Sex Med; 2011 Oct; 8(10):2904-11. PubMed ID: 21771281
    [Abstract] [Full Text] [Related]

  • 3. Sildenafil or vardenafil nonresponders' erectile response to tadalafil.
    Ozgur BC, Gonenc F, Yazicioglu AH.
    Urol J; 2009 Oct; 6(4):267-71. PubMed ID: 20027555
    [Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of vardenafil in East Asian men with erectile dysfunction.
    Chen KK, Paick JS, Ishii N, On Behalf Of The Vardenafil Study Group.
    J Sex Med; 2007 May; 4(3):753-761. PubMed ID: 17498108
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives.
    van Ahlen H, Wahle K, Kupper W, Yassin A, Reblin T, Neureither M.
    J Sex Med; 2005 Nov; 2(6):856-64. PubMed ID: 16422810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.
    Porst H, Sharlip ID, Hatzichristou D, Rubio-Aurioles E, Gittelman M, Stancil BN, Smith PM, Wilkins HJ, Pommerville P, Vardenafil Study Group.
    Eur Urol; 2006 Nov; 50(5):1086-94; discussion 1094-5. PubMed ID: 16820261
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G, Nelli F, Celso M, Mencarini M, Del Popolo G.
    J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
    [Abstract] [Full Text] [Related]

  • 10. The effect of physician and patient education when combined with vardenafil treatment in Canadian males with erectile dysfunction: an open-label, factorial-designed, cluster-randomized clinical trial.
    Brock G, Carrier S, Alarie P, Pommerville P, Casey R, Harris S, Ward R.
    J Sex Med; 2008 Mar; 5(3):705-15. PubMed ID: 18304285
    [Abstract] [Full Text] [Related]

  • 11. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
    Rubio-Aurioles E, Porst H, Eardley I, Goldstein I.
    J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F, Aversa A, Moncada I, Perimenis P, Porst H, Barker C, Shane MA, Sorsaburu S.
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [Abstract] [Full Text] [Related]

  • 13. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
    Sperling H, Debruyne F, Boermans A, Beneke M, Ulbrich E, Ewald S.
    J Sex Med; 2010 Apr; 7(4 Pt 1):1497-507. PubMed ID: 20233275
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials.
    Sperling H, Gittelman M, Norenberg C, Ulbrich E, Ewald S.
    J Sex Med; 2011 Jan; 8(1):261-71. PubMed ID: 20807322
    [Abstract] [Full Text] [Related]

  • 15. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Mulhall JP, McLaughlin TP, Harnett JP, Scott B, Burhani S, Russell D.
    J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
    [Abstract] [Full Text] [Related]

  • 16. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
    Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata AR, Maggi M, Mansani R, Palego P, Spera G, Vetri M, Lenzi A, Endotrial Study Group.
    J Sex Med; 2009 Sep; 6(9):2547-60. PubMed ID: 19570039
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study.
    Miner MM, Barnes A, Janning S.
    J Sex Med; 2010 May; 7(5):1937-47. PubMed ID: 20202105
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction.
    Tan HM, Chin CM, Chua CB, Gatchalian E, Kongkanand A, Moh CL, Ng FC, Ratana-Olarn K, Serrano D, Taher A, Tambi I, Tantiwong A, Chen MW, Yip WC.
    Asian J Androl; 2008 May; 10(3):495-502. PubMed ID: 18385912
    [Abstract] [Full Text] [Related]

  • 19. Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management.
    Scranton RE, Goldstein I, Stecher VJ.
    J Sex Med; 2013 Feb; 10(2):551-61. PubMed ID: 23153075
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E, Seftel A, Goldfischer E, Baygani S, Burns P.
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.